SAN DIEGO--(BUSINESS WIRE)--A new study concludes that the POWERWAND® peripheral IV (PIV) catheter is an effective alternative to central lines and standard PIV’s, achieving unprecedented levels of success in patients requiring longer-term IV therapy.
